Peter Salzmann
Chief Executive Officer presso IMMUNOVANT, INC.
Patrimonio netto: 34 M $ in data 31/03/2024
Posizioni attive di Peter Salzmann
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 06/03/2020 | - |
| Independent Dir/Board Member | 06/03/2020 | - | |
| IMMUNOVANT, INC. | Director/Board Member | 01/10/2019 | - |
| Chief Executive Officer | 01/06/2019 | - | |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Director/Board Member | - | - |
| IMVT Corp. | Chief Executive Officer | - | - |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The private company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Director/Board Member | 01/10/2019 | - |
Storia della carriera di Peter Salzmann
Precedenti posizioni note di Peter Salzmann
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2011 | 01/06/2019 |
| Eli Lilly Asia, Inc. | Sales & Marketing | 01/01/2008 | 01/12/2010 |
Formazione di Peter Salzmann
| Northwestern University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
| Pritzker School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
| Cina | 2 |
| Bermuda | 2 |
Posizioni
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| IMMUNOVANT, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Health Technology |
| Eli Lilly Asia, Inc. | |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The private company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Health Technology |
| IMVT Corp. |
- Borsa valori
- Insiders
- Peter Salzmann
- Esperienza
